These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30746340)

  • 1. Celastrol Inhibits the Growth of Ovarian Cancer Cells
    Xu LN; Zhao N; Chen JY; Ye PP; Nan XW; Zhou HH; Jiang QW; Yang Y; Huang JR; Yuan ML; Xing ZH; Wei MN; Li Y; Shi Z; Yan XJ
    Front Oncol; 2019; 9():2. PubMed ID: 30746340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.
    Jiang QW; Cheng KJ; Mei XL; Qiu JG; Zhang WJ; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Zhang X; Lv M; Chen MW; Wei X; Shi Z
    Oncotarget; 2015 Oct; 6(32):32790-804. PubMed ID: 26447544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.
    Yang H; Chen D; Cui QC; Yuan X; Dou QP
    Cancer Res; 2006 May; 66(9):4758-65. PubMed ID: 16651429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells.
    Li X; Wang H; Ding J; Nie S; Wang L; Zhang L; Ren S
    Eur J Pharmacol; 2019 Jan; 842():146-156. PubMed ID: 30389635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the Effect of Celastrol Against Ovarian Cancer With Network Pharmacology and
    Wang X; Liu Q; Wu S; Xu N; Li H; Feng A
    Front Pharmacol; 2022; 13():739478. PubMed ID: 35370699
    [No Abstract]   [Full Text] [Related]  

  • 6. Celastrol: Molecular targets of Thunder God Vine.
    Salminen A; Lehtonen M; Paimela T; Kaarniranta K
    Biochem Biophys Res Commun; 2010 Apr; 394(3):439-42. PubMed ID: 20226165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications.
    Wagh PR; Desai P; Prabhu S; Wang J
    Front Pharmacol; 2021; 12():673209. PubMed ID: 34177584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells.
    De U; Son JY; Jeon Y; Ha SY; Park YJ; Yoon S; Ha KT; Choi WS; Lee BM; Kim IS; Kwak JH; Kim HS
    Food Chem Toxicol; 2019 Jan; 123():492-500. PubMed ID: 30458268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells.
    Li X; Zhu G; Yao X; Wang N; Hu R; Kong Q; Zhou D; Long L; Cai J; Zhou W
    Onco Targets Ther; 2018; 11():8977-8985. PubMed ID: 30588010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celastrol Loaded Nanoparticles With ROS-Response and ROS-Inducer for the Treatment of Ovarian Cancer.
    Niu W; Wang J; Wang Q; Shen J
    Front Chem; 2020; 8():574614. PubMed ID: 33195064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of WEE1 Suppresses the Tumor Growth in Laryngeal Squamous Cell Carcinoma.
    Yuan ML; Li P; Xing ZH; Di JM; Liu H; Yang AK; Lin XJ; Jiang QW; Yang Y; Huang JR; Wang K; Wei MN; Li Y; Ye J; Shi Z
    Front Pharmacol; 2018; 9():1041. PubMed ID: 30323762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol inhibits migration and invasion through blocking the NF-κB pathway in ovarian cancer cells.
    Wang Z; Zhai Z; Du X
    Exp Ther Med; 2017 Jul; 14(1):819-824. PubMed ID: 28673005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate.
    Greenshields AL; Shepherd TG; Hoskin DW
    Mol Carcinog; 2017 Jan; 56(1):75-93. PubMed ID: 26878598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovatodiolide isolated from Anisomeles indica induces cell cycle G2/M arrest and apoptosis via a ROS-dependent ATM/ATR signaling pathways.
    Yu CY; Jerry Teng CL; Hung PS; Cheng CC; Hsu SL; Hwang GY; Tzeng YM
    Eur J Pharmacol; 2018 Jan; 819():16-29. PubMed ID: 28986085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural terthiophene α-terthienylmethanol induces S phase cell cycle arrest of human ovarian cancer cells via the generation of ROS stress.
    Preya UH; Lee KT; Kim NJ; Lee JY; Jang DS; Choi JH
    Chem Biol Interact; 2017 Jun; 272():72-79. PubMed ID: 28506552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erianin induces G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo.
    Wang H; Zhang T; Sun W; Wang Z; Zuo D; Zhou Z; Li S; Xu J; Yin F; Hua Y; Cai Z
    Cell Death Dis; 2016 Jun; 7(6):e2247. PubMed ID: 27253411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzyl isothiocyanate (BITC) induces G2/M phase arrest and apoptosis in human melanoma A375.S2 cells through reactive oxygen species (ROS) and both mitochondria-dependent and death receptor-mediated multiple signaling pathways.
    Huang SH; Wu LW; Huang AC; Yu CC; Lien JC; Huang YP; Yang JS; Yang JH; Hsiao YP; Wood WG; Yu CS; Chung JG
    J Agric Food Chem; 2012 Jan; 60(2):665-75. PubMed ID: 22148415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crizotinib synergizes with cisplatin in preclinical models of ovarian cancer.
    Huang XX; Xie FF; Hou LJ; Chen XX; Ou RY; Yu JT; Qiu JG; Zhang WJ; Jiang QW; Yang Y; Zheng DW; Chen Y; Huang JR; Wang K; Wei MN; Li WF; Shi Z; Yan XJ
    Am J Transl Res; 2017; 9(4):1667-1679. PubMed ID: 28469773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1.
    Xu H; Zhao H; Ding C; Jiang D; Zhao Z; Li Y; Ding X; Gao J; Zhou H; Luo C; Chen G; Zhang A; Xu Y; Zhang H
    Signal Transduct Target Ther; 2023 Feb; 8(1):51. PubMed ID: 36732502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.